ADXS : Insider Transactions for Advaxis Inc

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

New Search

Get Insiders for :

Advaxis Inc (ADXS)

$0.06 0.00 (0.00%) as of 4:30 Fri 6/3

Download

Exchange:

OTC Bulletin Board

Security Type:

Common

Shares Out:

66,230,000

Market Cap:

4.11(M)

Last Volume:

362,100

Avg Vol:

358,710

52 Week Range:

$0.062 - $0.062

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	1,317,716	1,317,716
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	1	1
Total Buy Transactions	0	0	1	1
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-06-27	2024-03-26	2023-09-26	2022-09-26

Adjust Filter Settings

Records found: 454

Page 19 of 19

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

French Christy Lee

VP-Regulatory, Medical Affairs

• – –

2014-07-01

$3.15

$189

D/D

(60)

79,102

French Christy Lee

VP-Regulatory, Medical Affairs

• – –

2014-07-01

$0.00

D/D

503

79,162

Petit Robert

Chief Scientific Officer

• – –

2014-07-01

$3.15

$665

D/D

(211)

119,883

Petit Robert

Chief Scientific Officer

• – –

2014-07-01

$0.00

D/D

1,183

120,094

454 Records found	Previous 10 11 12 13 14 15 16 17 18 19	Page 19 of 19

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: